Premium
A SINGLE‐ARM, OPEN‐LABEL, PILOT TRIAL OF AUTOLOGOUS CD7‐CAR‐T CELLS FOR CD7 POSITIVE RELAPSED AND REFRACTORY T‐LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Author(s) -
Zhang M.,
Zhang M.,
Fu X.,
Meng H.,
Chen D.,
Wang M.,
Zhang L.,
Li L.,
Li X.,
Wang X.,
Sun Z.,
Yu H.,
Li Z.,
Nan F.,
Chang Y.,
Zhou Z.,
Yan J.,
Li J.,
Wang Y.,
You F.,
Wang Y.,
Xiang S.,
Chen Y.,
Pan G.,
Xu H.,
Zhang B.,
Yang L.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.181_2880
Subject(s) - medicine , lymphoblastic lymphoma , lymphoma , chimeric antigen receptor , leukemia , refractory (planetary science) , t cell , oncology , antigen , cancer research , immunology , biology , immune system , astrobiology